Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scavenger cells could be key to treating HIV-related dementia

15.09.2005


Understanding macrophages could lead to ways to prevent HIV-associated dementia



Bacteria-eating cells that generally fight infection may cause dementia in HIV patients, University of Florida and University of California at San Francisco researchers have found.

Macrophages, long-living white blood cells often considered the scavengers of the immune system, actually may damage a part of the brain where many memories are stored in their attempt to attack the virus there, according to findings reported in the Journal of Virology this month.


Researchers found that HIV-infected macrophages in the brain continuously travel to the temporal lobe, a part of the brain Alzheimer’s disease often damages. Because the virus mutates nearly 100 times faster in the temporal lobe than other parts of the brain, attacking macrophages migrate there in a constant stream, causing harmful inflammation.

Nearly 15 percent of HIV patients develop dementia as their disease progresses. But understanding the routes macrophage cells take in the brain could help researchers find ways to block the migration and prevent HIV-associated dementia, said Marco Salemi, Ph.D, a UF assistant professor of pathology and immunology and an author of the study.

"In a way, it’s not the virus that directly causes the dementia," Salemi said. "It’s the fact that there is this continuous migration of infected macrophages to the temporal lobe. The virus mutates much faster there, the macrophages keep accumulating and keep creating this inflammation that leads to dementia."

Macrophages also may explain why current drugs cannot kill the virus that causes AIDS.

Researchers have known for years how HIV replicates in T cells, also part of the immune system. But most are just beginning to understand how the virus affects macrophages, said Michael S. McGrath, M.D., Ph.D, a UCSF professor of pathology and laboratory medicine who co-authored the study.

"It’s likely the oldest (form of the) virus lives in a macrophage in the brain and most virus strains evolve from that," McGrath said. "Imagine having cells, already infected, that live as long as you do."

Current antiretroviral drugs block HIV from replicating in new T cells, but don’t kill the virus in infected macrophages. And the drugs cannot stop the virus from evolving into new forms, McGrath said. Because the virus mutates faster than other cells in the body, it also can develop resistance to these drugs, Salemi said.

Even the HIV already in an infected person’s brain is not one single virus, but rather populations of slightly different viruses that infect different parts of the brain, the findings show.

"We agree there are different strains that populate different regions of the brain," said Francisco Gonzalez-Scarano, M.D., chairman of the University of Pennsylvania neurology department. "We’ve done similar studies in monkeys."

To obtain their findings, the researchers studied different regions of the brain of a person who died with HIV-associated dementia using specimens from the AIDS and Cancer Specimen Resource at UCSF. They also used a new computer-based research tool to study the results. Dubbed phylodynamic analysis, this new method links traditional ways of studying the virus to give researchers a more comprehensive understanding, which Salemi says is crucial to analyzing the ever-changing disease.

"If we really want to understand what happens to a person infected with this disease, we need to develop new tools," he said. "We can put together all these different resources and describe how the virus changes over time and try to understand why this particular damage happens"

But these results are just a first step, Salemi said. The team is now analyzing brains from 10 people, some who died with HIV-associated dementia and others who did not.

The well-known cocktail of antiretroviral drugs prescribed to most HIV patients has cut the number of HIV-associated dementia cases reported each year, Gonzalez-Scarano said. However, this is because the drugs slow the progression of the disease, he said. Patients still have the same chance of developing dementia later, as the disease advances.

That’s one of the reasons why the researchers say developing drugs that target macrophages as well as T cells is important. These drugs could provide better treatments for dementia and potentially lead to a way to "eradicate HIV-1 infection," the study states.

"You can’t cure (HIV) with antiretroviral therapy (alone)," McGrath said.

April Frawley Birdwell | EurekAlert!
Further information:
http://www.health.ufl.edu

More articles from Life Sciences:

nachricht Rainbow colors reveal cell history: Uncovering β-cell heterogeneity
22.09.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden

nachricht The pyrenoid is a carbon-fixing liquid droplet
22.09.2017 | Max-Planck-Institut für Biochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>